REFERENCES
- KoobGF.VolkowND.Neurobiology of addiction: a neurocircuitry analysis.Lancet Psychiatry.20163876077327475769
- MadrasBK.The surge of opioid use, addiction, and overdoses: responsibility and response of the US health care system.JAMA Psychiatry.201774544144228355456
- Center for Behavioral Health Statistics and Quality. Results from the 2011 National Survey on Drug Use and Health: summary of national findings (HHS publication No. SMA 12-4713, NSDUH series H-44). Rockville, MD: Substance Abuse and Mental Health Services Administration; 2012.
- HanB.ComptonWM.JonesCM.CaiR.Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003-2013.JAMA.2015314141468147826461997
- Centers for Disease Controls National Vital Statistics System. Multiple cause of death file. Atlanta, GA: Centers for Disease Control and Prevention; 2012. Available at: www.cdc.gov/nchs/data/dvs/Record_Layout_2012. pdf.
- BradyKT.McCauleyJL.BackSE.Prescription opioid misuse, abuse, and treatment in the United States: an update.Am J Psychiatry.201617311926725336
- VowlesKE.McEnteeML.JulnesPE.FroheT.NeyJP.van der GoesDN.Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis.Pain.2015156456958025785523
- SmithSM.DartRC.KatzNP.et alClassification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations.Pain.2013154112287279623792283
- O'ConnorAB.TurkDC.DworkinRH.et alAbuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations.Pain.2013154112324233424148704
- CheatleM.Facing the challenge of pain management and opioid misuse, abuse and opioid-related fatalities.Expert Rev Clin Pharmacol.20169675175426933873
- GrantBF.SahaTD.RuanWJ.et alEpidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III.JAMA Psychiatry.2016731394726580136
- WilkersonRG.KimHK.WindsorTA.MareinissDP.The opioid epidemic in the United States.Emerg Med Clin N Am.2016342e1e23
- JonesCM.Frequency of prescription pain reliever nonmedical use: 2002-2003 and 2009-2010.Arch Intern Med.2012172161265126722733257
- PaulozziL.JonesC.MackK.et alCenters for Disease Control and Prevention (CDC). Vital signs: overdoses of prescription opioid analgesics—United States, 1999-2008.MMWR Morb Mortal Wkly Rep.201160431487149222048730
- MurrayCJ.VosT.LozanoR.et alDisability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.Lancet.201238098592197222323245608
- DegenhardtL.WhitefordHA.FerrariAJ.et alGlobal burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010.Lancet.201338299041564157423993281
- TsuangMT.LyonsMJ.MeyerJM.et alCo-occurrence of abuse of different drugs in men.Arch Gen Psychiatry.199855119679729819064
- KendlerKS.JacobsonKC.PrescottCA.NealeMC.Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins.Am J Psychiatry.2003160468769512668357
- GelernterJ.KranzlerHR.ShervaR.et alGenome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways.Biol Psychiatry.2014761667424143882
- NelsonEC.AgrawalA.HeathAC.et alEvidence of CNIH3 involvement in opioid dependence.Mol Psychiatry.201621560861426239289
- Van den OeverMC.GoriounovaNA.LiKW.et alPrefrontal cortex AMPA receptor plasticity is crucial for cue-induced relapse to heroin-seeking.Nat Neurosci.20081191053105819160503
- CaiYQ.WangW.HouYY.ZhangZ.XieJ.PanZZ.Central amygdala GluA1 facilitates associative learning of opioid reward.J Neurosci.20133341577158823345231
- PlichtaMM.GrimmO.MorgenK.et alAmygdala habituation: a reliable fMRI phenotype.Neuroimage.201410338339025284303
- ColantuoniC.LipskaBK.YeT.et alTemporal dynamics and genetic control of transcription in the human prefrontal cortex.Nature.2011478737051952322031444
- HancockDB.LevyJL.GaddisNC.et al Cis-expression quantitative trait loci mapping reveals replicable associations with heroin addiction in OPRM1 Biol Psychiatry.201578747448425744370
- Schwantes-AnTH.ZhangJ.ChenLS.et alAssociation of the OPRM1 variant rs1799971 (A118G) with non-specific liability to substance dependence in a collaborative de novo meta-analysis of European-ancestry cohorts.Behav Genet.201646215116926392368
- HaerianBS.HaerianMS. OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis.Pharmacogenomics.201314781382423651028
- LiD.ZhaoH.KranzlerHR.et alGenome-wide association study of copy number variations (CNVs) with opioid dependence.Neuropsychopharmacology.20154041016102625345593
- de CidR.Riveira-MunozE.ZeeuwenPL.et alDeletion of the late cornified envelope (LCE) 3B and 3C genes as a susceptibility factor for psoriasis.Nat Genet.200941221121519169253
- DocampoE.RabionetR.Riveira-MunozE.et alDeletion of the late cornified envelope genes, LCE3C Cand LCE3B, is associated with rheumatoid arthritis.Arthritis Rheum.20106251246125120213803
- LuX.GuoJ.ZhouX.et alDeletion of LCE3C_LCE3B is associated with rheumatoid arthritis and systemic lupus erythematosus in the Chinese Han population.Ann Rheum Dis.20117091648165121628307
- DennisBB.BaworM.ThabaneL.SohaniZ.SamaanZ.Impact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: a systematic review and meta-analysis.PLoS One.201491e8611424489693
- SmithAH.JensenKP.LiJ.et alGenome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1.Mol Psychiatry.201722334635228115739
- YangHC.ChuSK.HuangCL.et alGenome-wide pharmacogenomic study on methadone maintenance treatment identifies SNP rs17180299 and multiple haplotypes on CYP2B6, SPON1, and GSG1L associated with plasma concentrations of methadone R- and S-enantiomers in heroindependent patients.PLoS Genet.2016123e1005910.27010727
- BersonA.FauD.FornacciariR.et alMechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation.J Hepatol.200134226126911281555
- SaxonAJ.LingW.HillhouseM.et alBuprenorphine/naloxone and methadone effects on laboratory indices of liver health: a randomized trial.Drug Alcohol Depend.20131281-2717622921476
- CristRC.ClarkeTK.AngA.et alAn intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.Neuropsychopharmacology.201338102003201023612435
- RoussotteFF.JahanshadN.HibarDP.et alA commonly carried genetic variant in the delta opioid receptor gene, OPRD1 is associated with smaller regional brain volumes: replication in elderly and young populations.Hum Brain Mapp.20143541226123623427138
- CristRC.Ambrose-LanciLM.VaswaniM.et alCase-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populations.Drug Alcohol Depend.20131271-312212822795689
- NishizawaD.FukudaK.KasaiS.et alGenome-wide association study identifies a potent locus associated with human opioid sensitivity.Mol Psychiatry.2014191556223183491